BackHorizon Therapeutics Plc Overview
Horizon Therapeutics Plc

Horizon Therapeutics Plc Target Price

Explore Horizon Therapeutics Plc's target price with historical charts and peer comparisons.

Get informed when a big investor buys or sells

+ Follow

Share Price

$116.3

Average Target Price

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2022-12-13Guggenheim$116.50.2% upsideOpen
2022-12-13Leerink Partners$116.50.2% upsideOpen
2022-12-13Wells Fargo$116.50.2% upsideOpen
2022-12-07Piper Sandler$1105.4% downsideOpen
2022-08-03Stifel NicolausAnnabel Samimy$13818.7% upsideOpen
2022-07-05UBSAshwani Verma$13717.8% upsideOpen
2022-06-13UBSAshwani Verma$13919.5% upsideOpen
2022-03-17OppenheimerLeland Gershell$14020.4% upsideOpen
2021-10-26Bank of America SecuritiesJason Gerberry$14423.8% upsideOpen
2021-10-06JefferiesAkash Tewari$13213.5% upsideOpen
2021-08-05CitigroupNavann Ty$1214% upsideOpen

Horizon Therapeutics Plc (HZNP) FAQ

Stockcircle tracks target price for Horizon Therapeutics Plc (HZNP), including historical charts and peer comparisons when data is available. Check back as new filings are published, or open the stock overview for a broader fundamental snapshot.

This Target Price page is built for Horizon Therapeutics Plc's historical target price trend and peer context. When enough reporting periods are on file, the charts below visualize how the metric has moved over time.

Use target price as one input alongside growth, profitability, valuation, and ownership activity. Stockcircle links related metric pages and the main HZNP overview so you can move from this figure to the surrounding analysis quickly.